myopia. Visual disturbances and blindness
Conditions
Interventions
Intervention 1: One eye was randomly assigned to receive intraoperative topical MMC, and Balanced Salt Solution (BSS) was used in control group. In each subject, MMC 0.02% (0.2 mg/ml) solution was app
Treatment - Drugs
One eye was randomly assigned to receive intraoperative topical MMC, and Balanced Salt Solution (BSS) was used in control group. In each subject, MMC 0.02% (0.2 mg/ml) solution was applied on the abla
In control group BSS was applied on the ablated zone.
Sponsors
Basir eye center
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Myopic patients with ablation depths less than 65 µm. Exclusion criteria: Patients with unstable refraction, suspicion of keratoconus, excessive dry eyes, impaired wound healing processes, lenticular changes, corneal dystrophy, history of ocular surgery, anterior or posterior uveitis, glaucoma, and retinal diseases.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endothelial cell density. Timepoint: pre surgical and 3 and 6 months post surgical. Method of measurement: specular microscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Aslani
Tehran University of Medical Sciences
Outcome results
None listed